Combined Muscle Biopsy and Comprehensive Electrophysiology in General Anesthesia is Valuable in Diagnosis of Neuromuscular Disease in Children
Thieme. All rights reserved..
AIM: The diagnostic workup in patients with delayed motor milestones suspected of having either myopathy or a congenital myasthenic syndrome is complex. Our hypothesis was that performance of a muscle biopsy and neurophysiology including stimulated single-fiber electromyography during an anesthetic procedure, combined with genetic testing has a high diagnostic quality.
MATERIALS AND METHODS: Clinical and paraclinical data were retrospectively collected from 24 patients aged from 1 month to 10 years (median: 5.2 years).
RESULTS: Neurophysiology examination was performed in all patients and was abnormal in 11 of 24. No patients had findings suggestive of a myasthenic syndrome. Muscle biopsy was performed in 21 of 24 and was normal in 16. Diagnostic findings included nemaline rods, inclusion bodies, fiber size variability, and type-II fiber atrophy. Genetic testing with either a gene panel or exome sequencing was performed in 18 of 24 patients, with pathogenic variants detected in ACTA1, NEB, SELENON, GRIN2B, SCN8A, and COMP genes.
CONCLUSION: Results supporting a neuromuscular abnormality were found in 15 of 24. In six patients (25%), we confirmed a genetic diagnosis and 12 had a clinical neuromuscular diagnosis. The study suggests that combined use of neurophysiology and muscle biopsy in cases where genetic testing does not provide a diagnosis can be useful in children with delayed motor milestones and clinical evidence of a neuromuscular disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
---|---|
Enthalten in: |
Neuropediatrics - 52(2021), 6 vom: 11. Dez., Seite 462-468 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hoei-Hansen, Christina E [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 06.04.2022 Date Revised 06.04.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1055/s-0041-1726120 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM322633044 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM322633044 | ||
003 | DE-627 | ||
005 | 20231225182444.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1055/s-0041-1726120 |2 doi | |
028 | 5 | 2 | |a pubmed24n1075.xml |
035 | |a (DE-627)NLM322633044 | ||
035 | |a (NLM)33706403 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hoei-Hansen, Christina E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Combined Muscle Biopsy and Comprehensive Electrophysiology in General Anesthesia is Valuable in Diagnosis of Neuromuscular Disease in Children |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.04.2022 | ||
500 | |a Date Revised 06.04.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Thieme. All rights reserved. | ||
520 | |a AIM: The diagnostic workup in patients with delayed motor milestones suspected of having either myopathy or a congenital myasthenic syndrome is complex. Our hypothesis was that performance of a muscle biopsy and neurophysiology including stimulated single-fiber electromyography during an anesthetic procedure, combined with genetic testing has a high diagnostic quality | ||
520 | |a MATERIALS AND METHODS: Clinical and paraclinical data were retrospectively collected from 24 patients aged from 1 month to 10 years (median: 5.2 years) | ||
520 | |a RESULTS: Neurophysiology examination was performed in all patients and was abnormal in 11 of 24. No patients had findings suggestive of a myasthenic syndrome. Muscle biopsy was performed in 21 of 24 and was normal in 16. Diagnostic findings included nemaline rods, inclusion bodies, fiber size variability, and type-II fiber atrophy. Genetic testing with either a gene panel or exome sequencing was performed in 18 of 24 patients, with pathogenic variants detected in ACTA1, NEB, SELENON, GRIN2B, SCN8A, and COMP genes | ||
520 | |a CONCLUSION: Results supporting a neuromuscular abnormality were found in 15 of 24. In six patients (25%), we confirmed a genetic diagnosis and 12 had a clinical neuromuscular diagnosis. The study suggests that combined use of neurophysiology and muscle biopsy in cases where genetic testing does not provide a diagnosis can be useful in children with delayed motor milestones and clinical evidence of a neuromuscular disease | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Tygesen, Marie L B |e verfasserin |4 aut | |
700 | 1 | |a Dunø, Morten |e verfasserin |4 aut | |
700 | 1 | |a Vissing, John |e verfasserin |4 aut | |
700 | 1 | |a Ballegaard, Martin |e verfasserin |4 aut | |
700 | 1 | |a Born, Alfred P |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neuropediatrics |d 1993 |g 52(2021), 6 vom: 11. Dez., Seite 462-468 |w (DE-627)NLM012996483 |x 1439-1899 |7 nnns |
773 | 1 | 8 | |g volume:52 |g year:2021 |g number:6 |g day:11 |g month:12 |g pages:462-468 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/s-0041-1726120 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 52 |j 2021 |e 6 |b 11 |c 12 |h 462-468 |